In order to be marketed on the French market, a food supplement must be subject to a prior declaration to the competent authority in accordance with Decree No. 2006-352 on food supplements. Since February 3, 2023, food supplements have been declared to the Directorate General for Food using the online declaration platform téléicare.
The ashwaghanda is a plant extract you can find in the ingredient lists of food supplements, but do you know what is it exactly? This article makes a statement of what the science says established concerning this extract: its definition and health effects on human.
The World Gastroenterology Organization (WGO) recently released an updated guideline document, aimed at helping gastroenterologists and other physicians understand the appropriate clinical applications of probiotics or prebiotics. The guideline was created with input from experts in gastroenterology, probiotics and prebiotics, with efforts co-led by experts from the International Scientific Association for Probiotics and Prebiotics (ISAPP). To create these guidelines, experts comprehensively evaluated the evidence from randomized, controlled trials for gastrointestinal conditions, including which specific prebiotic strain or substance showed a positive effect. The guidelines present a list of conditions for which there is positive evidence for the effectiveness of probiotics and/or prebiotics.
WHO/Europe is calling upon consumers to become a part of a project aimed at creating a healthier society. Indeed, consumers can participate to the test of an artificial intelligence (AI) tool that will help countries across the WHO European Region to effectively monitor and regulate the promotion of harmful products from tobacco and alcohol to foods high in salt, trans fats and sugars – and to monitor the marketing of breastmilk substitutes and foods for infants and young children.
Starting from 2023, some food law aspects previously managed by the DGCCRF are transferred to the DGAL. What are the practical consequences for food supplements?
The cannabidiol, CBD, an active substance most often of natural origin, is one of the phyto-cannabinoids. CBD, as the tétrahydrocannabinol (THC ), is present in the cannabis flowers and leaves. It is a non-addictive psychotropic drug, unlike THC. It is also a component in the form of an extract, medicine, or everyday consumer products, only some of which are authorised in France under specific conditions of THC content. In addition, CBD is considered at European level as a novel food whose safety is currently being assessed by EFSA.
Following an exploration of potential regulatory pathways for cannabidiol (CBD) products by an internal Food and Drug Administration (FDA) working group, the FDA concluded on January 26, 2023, that a new regulatory pathway for CBD is needed to provide the regulatory oversight necessary to manage risk. The Agency is prepared to work with Congress on this issue.
Background: in the Guidance on the implementation of Regulation N° 1924/2006 on nutrition and health claims: conclusions of the standing Committee on the food chain and animal health published in 2007, the probiotic term is considered as a health claim because it refers to the implied description or indication of a functionality on health.
The conditions of use of the ingredient are now set by Regulation (EU) 2022/860.
You may see a claim followed by an asterisk on a herbal food supplement marketed in the Netherlands. These food supplements are composed of one or more plant(s) or plant extract(s) claiming effects on health. In accordance with European regulations on nutritional and health claims, only scientifically substantiated claims are permitted.